Preclinical evaluation of the CDK4/6 inhibitor LEE011 in nasopharyngeal carcinoma (NPC) cell lines

被引：0
|
作者：
Ma, Brigette B.
Wong, Chi-Hang
Hui, Connie
Hui, Edwin P.
Chan, Anthony T. C.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-3773
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3773
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Preclinical selectivity profile of the CDK4/6 inhibitor ribociclib (LEE011) compared with that of palbociclib and abemaciclib
    Tiedt, Ralph
    Delach, Scott
    Kovats, Steven
    Horn, Thomas
    Acker, Michael
    Engstler, Barbara Schacher
    Caponigro, Giordano
    Su, Fei
    [J]. CANCER RESEARCH, 2017, 77
  • [2] CDK4/6 Inhibitor LEE011 Is a Potential Radiation-sensitizer in Head and Neck Squamous Cell Carcinoma: An In Vitro Study
    Tai, Tzong-Shyuan
    Lin, Pai-Mei
    Wu, Ching-Fang
    Hung, Shih-Kai
    Huang, Chung-I
    Wang, Chih-Chun
    Su, Yu-Chieh
    [J]. ANTICANCER RESEARCH, 2019, 39 (02) : 713 - 720
  • [3] PHASE I STUDY OF THE CDK4/6 INHIBITOR LEE011 IN PATIENTS WITH MALIGNANT RHABDOID TUMORS OR NEUROBLASTOMA
    Geoerger, B.
    Bourdeaut, F.
    DuBois, S. G.
    Geller, J. I.
    Marabelle, A.
    Pearson, A. D.
    Kan, R.
    Matano, A.
    Bhansali, S. G.
    Parasuraman, S.
    Chi, S. N.
    [J]. PEDIATRIC BLOOD & CANCER, 2014, 61 : S138 - S139
  • [4] The combination of JAK inhibitor, ruxolitinib, pan-PIM inhibitor, LGH447, and CDK4/6 inhibitor, LEE011, in a preclinical mouse model of myeloproliferative neoplasia
    Pinzon-Ortiz, Maria
    Rong, Xianhui
    Saci, Abdel
    Schlegel, Robert
    Vanasse, Gary
    Caponigro, Giordano
    Cao, Z. Alexander
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [5] THE COMBINATION OF JAK INHIBITOR RUXOLITINIB, PAN-PIM INHIBITOR LGH447, AND CDK4/6 INHIBITOR LEE011 IN A PRECLINICAL MOUSE MODEL OF MYELOPROLIFERATIVE NEOPLASIA
    Pinzon-Ortiz, M.
    Rong, X.
    Saci, A.
    Vanasse, G.
    Schlegel, R.
    Caponigro, G.
    Cao, Z. A.
    [J]. HAEMATOLOGICA, 2014, 99 : 252 - 252
  • [6] A phase I study of the single-agent CDK4/6 inhibitor LEE011 in pts with advanced solid tumors and lymphomas
    Infante, Jeffrey R.
    Shapiro, Geoffrey
    Witteveen, Petronella
    Gerecitano, John F.
    Ribrag, Vincent
    Chugh, Rashmi
    Issa, Isra
    Chakraborty, Abhijit
    Matano, Alessandro
    Zhao, Xumei
    Parasuraman, Sudha
    Cassier, Phillipe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] PHASE IB/II STUDY OF LEE011 (CDK4/6 INHIBITOR) AND LGX818 (BRAF INHIBITOR) IN BRAF-MUTANT MELANOMA
    Taylor, M.
    Sosman, J.
    Gonzalez, R.
    Carlino, M. S.
    Kittaneh, M.
    Lolkema, M. P.
    Miller, W.
    Marino, A.
    Zhang, V.
    Bhansali, S. G.
    Parasuraman, S.
    Postow, M. A.
    [J]. ANNALS OF ONCOLOGY, 2014, 25
  • [8] Molecular mechanism of G1 arrest and cellular senescence induced by LEE011, a novel CDK4/CDK6 inhibitor, in leukemia cells
    Yan-Fang Tao
    Na-Na Wang
    Li-Xiao Xu
    Zhi-Heng Li
    Xiao-Lu Li
    Yun-Yun Xu
    Fang Fang
    Mei Li
    Guang-Hui Qian
    Yan-Hong Li
    Yi-Ping Li
    Yi Wu
    Jun-Li Ren
    Wei-Wei Du
    Jun Lu
    Xing Feng
    Jian Wang
    Wei-Qi He
    Shao-Yan Hu
    Jian Pan
    [J]. Cancer Cell International, 17
  • [9] Molecular mechanism of G1 arrest and cellular senescence induced by LEE011, a novel CDK4/CDK6 inhibitor, in leukemia cells
    Tao, Yan-Fang
    Wang, Na-Na
    Xu, Li-Xiao
    Li, Zhi-Heng
    Li, Xiao-Lu
    Xu, Yun-Yun
    Fang, Fang
    Li, Mei
    Qian, Guang-Hui
    Li, Yan-Hong
    Li, Yi-Ping
    Wu, Yi
    Ren, Jun-Li
    Du, Wei-Wei
    Lu, Jun
    Feng, Xing
    Wang, Jian
    He, Wei-Qi
    Hu, Shao-Yan
    Pan, Jian
    [J]. CANCER CELL INTERNATIONAL, 2017, 17
  • [10] Anti-Cancer Effects of CDK4/6 Inhibitor LEE011 and Chemotherapy Drugs on Lymphocytic Leukemia L1210 Cells
    Lin, Yu-cheng
    Lin, Yuan-ho
    Chang, Yu
    Su, Yu-chieh
    Hsieh, Wen-chuan
    Chen, Wen-hui
    Lee, Hui-ming
    [J]. ANTICANCER RESEARCH, 2024, 44 (03) : 1121 - 1130
12345